• 1623 Citations
  • 22 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John M Slopis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Neurofibromatosis 1 Medicine & Life Sciences
Neurilemmoma Medicine & Life Sciences
Neurofibromatoses Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Sirolimus Medicine & Life Sciences
Brain Medicine & Life Sciences
Neurofibroma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

  • 1623 Citations
  • 22 h-Index
  • 53 Article
  • 5 Letter
  • 3 Review article
  • 1 Chapter
17 Citations (Scopus)

Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy

the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, Jan 1 2019, In : Nature Reviews Clinical Oncology. 16, 1, p. 45-63 19 p.

Research output: Contribution to journalReview article

Antigen Receptors
Cell- and Tissue-Based Therapy
Acute Lung Injury
7 Citations (Scopus)

The molecular landscape of glioma in patients with Neurofibromatosis 1

D’Angelo, F., Ceccarelli, M., Tala, Garofano, L., Zhang, J., Frattini, V., Caruso, F. P., Lewis, G., Alfaro, K. D., Bauchet, L., Berzero, G., Cachia, D., Cangiano, M., Capelle, L., de Groot, J., DiMeco, F., Ducray, F., Farah, W., Finocchiaro, G., Goutagny, S. & 27 others, Kamiya-Matsuoka, C., Lavarino, C., Loiseau, H., Lorgis, V., Marras, C. E., McCutcheon, I., Nam, D. H., Ronchi, S., Saletti, V., Seizeur, R., Slopis, J., Suñol, M., Vandenbos, F., Varlet, P., Vidaud, D., Watts, C., Tabar, V., Reuss, D. E., Kim, S. K., Meyronet, D., Mokhtari, K., Salvador, H., Bhat, K. P., Eoli, M., Sanson, M., Lasorella, A. & Iavarone, A., Jan 1 2019, In : Nature medicine. 25, 1, p. 176-187 12 p.

Research output: Contribution to journalArticle

Neurofibromatosis 1
Isocitrate Dehydrogenase
1 Citation (Scopus)

Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers

Young, E. D., Ingram, D., Metcalf-Doetsch, W., Khan, D., Al Sannaa, G., Le Loarer, F., Lazar, A., Slopis, J. M., Torres, K. E., Lev, D., Pollock, R. E. & McCutcheon, I. E., Sep 1 2018, In : Journal of neurosurgery. 129, 3, p. 805-814 10 p.

Research output: Contribution to journalArticle

Peripheral Nerves
11 Citations (Scopus)

Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex the TREATMENT randomized clinical trial

TREATMENT Trial Collaborators, Jul 1 2018, In : JAMA Dermatology. 154, 7, p. 773-780 8 p.

Research output: Contribution to journalArticle

Tuberous Sclerosis
Randomized Controlled Trials

Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial

Slopis, J. M., Arevalo, O., Bell, C. S., Hebert, A. A., Northrup, H., Riascos, R. F., Samuels, J. A., Smith, K. C., Tate, P. & Koenig, M. K., Dec 1 2018, In : Drugs in R and D. 18, 4, p. 295-302 8 p.

Research output: Contribution to journalArticle

Neurofibromatosis 1
Plexiform Neurofibroma
Outcome Assessment (Health Care)